110 related articles for article (PubMed ID: 12091008)
1. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Cockcroft JR; Brown MJ
Lancet; 2002 Jun; 359(9324):2202; author reply 2203-4. PubMed ID: 12091008
[No Abstract] [Full Text] [Related]
2. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Hamon M
Lancet; 2002 Jun; 359(9324):2199-200; author reply 2203-4. PubMed ID: 12091003
[No Abstract] [Full Text] [Related]
3. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Cruickshank JM
Lancet; 2002 Jun; 359(9324):2200-1; author reply 2203-4. PubMed ID: 12091004
[No Abstract] [Full Text] [Related]
4. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Bloom JM
Lancet; 2002 Jun; 359(9324):2201; author reply 2203-4. PubMed ID: 12091005
[No Abstract] [Full Text] [Related]
5. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
6. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Fuchs FD
Lancet; 2002 Jun; 359(9324):2203; author reply 2203-4. PubMed ID: 12091010
[No Abstract] [Full Text] [Related]
7. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Wiedermann CJ
Lancet; 2002 Jun; 359(9324):2199; author reply 2203-4. PubMed ID: 12091002
[No Abstract] [Full Text] [Related]
8. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Fournier A; Oprisiu R; Andrejak M; Fernandez L; Achard JM
JAMA; 2003 Feb; 289(6):700; author reply 701. PubMed ID: 12585946
[No Abstract] [Full Text] [Related]
9. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Messerli FH; Grossman E; Fournier A
JAMA; 2003 Feb; 289(6):700-1; author reply 701. PubMed ID: 12585945
[No Abstract] [Full Text] [Related]
10. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
11. Effects of losartan in hypertension without vascular disease.
Messerli FH
Ann Intern Med; 2004 Apr; 140(7):W29. PubMed ID: 15069010
[No Abstract] [Full Text] [Related]
12. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
[TBL] [Abstract][Full Text] [Related]
13. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
14. Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Ruwald AC; Westergaard B; Sehestedt T; Kjeldsen SE; Lindholm LH; Wachtell K; Devereux RB; Ibsen H; Nieminen MS; Dahlöf B; Olsen MH
J Hypertens; 2012 Jun; 30(6):1252-9. PubMed ID: 22499288
[TBL] [Abstract][Full Text] [Related]
15. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
[No Abstract] [Full Text] [Related]
16. Pulse pressure and antihypertensive agents.
Safar ME; O'Rourke MF
Hypertension; 2005 Aug; 46(2):e6; author reply e6-7. PubMed ID: 16027242
[No Abstract] [Full Text] [Related]
17. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Montastruc JL; Pathak A; Lapeyre-Mestre M
Lancet; 2002 Jun; 359(9324):2202; author reply 2203-4. PubMed ID: 12091009
[No Abstract] [Full Text] [Related]
18. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B; Devereux RB; Kjeldsen SE; Julius S; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristiansson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H;
Lancet; 2002 Mar; 359(9311):995-1003. PubMed ID: 11937178
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lindholm LH; Ibsen H; Dahlöf B; Devereux RB; Beevers G; de Faire U; Fyhrquist F; Julius S; Kjeldsen SE; Kristiansson K; Lederballe-Pedersen O; Nieminen MS; Omvik P; Oparil S; Wedel H; Aurup P; Edelman J; Snapinn S;
Lancet; 2002 Mar; 359(9311):1004-10. PubMed ID: 11937179
[TBL] [Abstract][Full Text] [Related]
20. [Kidney protection leads to heart protection, too].
MMW Fortschr Med; 2006 Aug; 148(33-34):57. PubMed ID: 16981393
[No Abstract] [Full Text] [Related]
[Next] [New Search]